Bone Fractures clinical trials

Explore recruiting bone fractures clinical trials.

Recruiting bone fractures studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Bone Fractures trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Open-Label, Multicenter, Randomized Study to evaluate the Efficacy and Safety of Romosozumab Compared with Bisphophonates in Children and Adolecents with Osteogenesis Imperfecta

Slovakia, Germany, Belgium, Spain, Hungary, Austria +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intraclass safety and efficacy comparison among SGLT-2 inhibitors in elderly patients with type 2 diabetes. A pragmatic, phase IV, multicenter, open-label, randomised controlled trial.

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Effects of a single denosumab injection on reduction of total contact cast treatment and consolidation of bone fractures caused by acute Charcot foot in patients with diabetes mellitus (CHARCOT study)

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety of different antimicrobial DURATions for the treatment of Infections associated with Osteosynthesis Material implanted after long bone fractures (DURATIOM). Phase 3 pragmatic multicenter open labelled randomized trial.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

A multi-centre, single-arm study to demonstrate the efficacy of bone marrow allogeneic mesenchymal cells combined with biomaterial (combined ATMP) for bone healing in delayed union and non-union after long bone fractures (OrthoAlloUnion).

Spain, Italy, France, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase I/II open label study to assess safety, feasibility and efficacy of ex vivo expanded, autologous haematopoietic stem and progenitor cell populations that contain CD34+ cells transduced with a lentiviral vector encoding the TCIRG1 cDNA in children with autosomal recessive osteopetrosis caused by mutations in the TCIRG1 gene.

Italy

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Bone Fractures trials by city

Bone Fractures in Toronto Bone Fractures in Vancouver Bone Fractures in Montreal Bone Fractures in Calgary Bone Fractures in Edmonton Bone Fractures in Ottawa Bone Fractures in Winnipeg Bone Fractures in Quebec City Bone Fractures in Hamilton Bone Fractures in Kitchener Bone Fractures in London Bone Fractures in Halifax Bone Fractures in New York Bone Fractures in Los Angeles Bone Fractures in Chicago Bone Fractures in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease